
A megadrought in the U.S. Southwest has triggered emergency measures…
June 2022
Comment uncategorized
By Mary Page Bailey |
Sandvik’s new powder plant in Sweden has recently received the ‘ISO 13485:2016’ medical certification for Osprey titanium powders, now approved for use in the additive manufacturing of medical applications.
Inside Sandvik’s titanium powder plant in Sandviken, Sweden (Source: Sandvik)
3D printing of implants enables rapid manufacturing directly from an individual’s anatomical data – enhancing the healing process and improving the prognosis for the patient.
“Achieving the ISO 13485:2016 medical certification will allow our medical customers to complete the necessary regulatory supplier approvals when bringing a medical application to market, utilizing Osprey® titanium powders from Sandvik,” says Keith Murray, VP and Head of Global Sales at division Additive Manufacturing.
Sandvik’s titanium powder plant in Sandviken, Sweden was inaugurated at the end of 2019. Earlier this year, the same powder plant also achieved the prestigious ‘AS9100D’ aerospace certification.
This publication contains text, graphics, images, and other content (collectively "Content"), which are for informational purposes only. Certain articles contain the author's personal recommendations only.
RELIANCE ON ANY INFORMATION SUPPLIED IN THIS PUBLICATION IS SOLELY AT YOUR OWN RISK.
©2022, Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity